Bayer Aktiengesellschaft (ETR:BAYN) Trading Up 1.8% – Still a Buy?

Shares of Bayer Aktiengesellschaft (ETR:BAYN) rose 1.8% during mid-day trading on Thursday . The stock traded as high as €34.77 and last traded at €34.70. Approximately 3,013,207 shares traded hands during trading, The stock had previously closed at €34.10.

Bayer Aktiengesellschaft Trading Up 1.7%

The firm has a market capitalization of $36.51 billion, a P/E ratio of -41.48, a price-to-earnings-growth ratio of 36.39 and a beta of 0.84. The company has a debt-to-equity ratio of 134.81, a quick ratio of 0.72 and a current ratio of 1.06. The firm has a 50 day moving average price of €38.53 and a two-hundred day moving average price of €38.69.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.